TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10578803

Group type: COMPARATOR
Intervention: Optimal breastfeeding technique alone
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Topical mupiricin
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Topical fusidic acid
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Oral antibiotics
Number of subjects: 84

Group type: COMPARATOR
Intervention: Not treated with systemic antibiotics
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Treated with systemic antibiotics
Number of subjects: 84
Study: 8916978

Group type: EXPERIMENTAL
Intervention: GnRH agonist therapy with add-back hormone replacement therapy (HRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zoladex (goserelin acetate) with add-back HRT
Number of subjects: 0
Study: 8417553

Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 89

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 89
Study: 3510196

Group type: EXPERIMENTAL
Intervention: Alprazolam with propranolol
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo with propranolol
Number of subjects: 27
Study: 29378227

Group type: EXPERIMENTAL
Intervention: Middle-aged trained (MAT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Young trained (YT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Young groups
Number of subjects: 40

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 40
Study: 26831299

Group type: EXPERIMENTAL
Intervention: Continuous infusion of GLP-1 at 0.6 pmol kg(‐1) min(‐1) (1 ml/min)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pulsatile infusion of GLP-1 with a bolus of 3.6 pmol/kg every 6 min (placebo at 1 ml/min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo infusion (1 ml/min)
Number of subjects: 12
Study: 23715004

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intranasal steroid (INS)
Number of subjects: 0
Study: 21334899

Group type: EXPERIMENTAL
Intervention: Oculo-motor exercises and gaze stability exercises for three weeks
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 41
Study: 19808377

Group type: EXPERIMENTAL
Intervention: Plasma urocortin 1 levels in patients with heart failure
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Plasma urocortin 1 levels
Number of subjects: 299
Study: 17803204

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 44
Study: 15468186

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (4 mg twice daily)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 11576162

Group type: EXPERIMENTAL
Intervention: Resistance training (TR)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 21
Study: 9403533

Group type: EXPERIMENTAL
Intervention: Cefepime plus metronidazole (n=164)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Imipenem-cilastatin (n=159)
Number of subjects: 323
Study: 8273766

Group type: EXPERIMENTAL
Intervention: Buprenorphine 2 mg/d sublingually
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 2949024

Group type: EXPERIMENTAL
Intervention: Teicoplanin (400 mg loading dose followed by 200 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Flucloxacillin (8 g/day)
Number of subjects: 0
Study: 29444664

Group type: EXPERIMENTAL
Intervention: 12-week knitting program including bi-weekly 20-min knitting sessions at a senior's club and 20-min home daily knitting sessions for five weekdays.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Educational pamphlet on osteoarthritis (OA) designed by the Arthritis Society.
Number of subjects: 0
Study: 26105060

Group type: EXPERIMENTAL
Intervention: Empowerment theory-based education program
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard education program
Number of subjects: 86
Study: 24469621

Group type: EXPERIMENTAL
Intervention: Emergency endovascular repair (EVAR)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Open surgical repair
Number of subjects: 147
Study: 22563440

Group type: EXPERIMENTAL
Intervention: Oral itraconazole 5 mg/kg/d for 24 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo for 24 weeks
Number of subjects: 35
Study: 20881073

Group type: EXPERIMENTAL
Intervention: Arginine-supplemented perioperative enteral nutrition (n = 17)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard perioperative enteral nutrition (n = 15)
Number of subjects: 32
Study: 18213374

Group type: EXPERIMENTAL
Intervention: Malaria vaccine FMP2.1/AS02A (25 microg/0.25 mL or 50 microg/0.5 mL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Malaria vaccine FMP2.1/AS02A (half-dose)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Malaria vaccine FMP2.1/AS02A (full-dose)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rabies vaccine (RabAvert)
Number of subjects: 60
Study: 15734497

Group type: EXPERIMENTAL
Intervention: Shunt of Continuous Flow (SCF)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Conventional Valvular Shunt
Number of subjects: 307
Study: 12671339

Group type: EXPERIMENTAL
Intervention: Growth hormone therapy
Number of subjects: 0
Study: 10375153

Group type: EXPERIMENTAL
Intervention: High-fidelity assertive community treatment programs
Number of subjects: 87

Group type: COMPARATOR
Intervention: Low-fidelity assertive community treatment programs
Number of subjects: 87
Study: 8889481

Group type: COMPARATOR
Intervention: CC (cool environment)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CH (hot, humid environment)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: HH (hot, humid environment)
Number of subjects: 12
Study: 1872343

Group type: EXPERIMENTAL
Intervention: Clindamycin (450 mg, orally four times daily for 14 days)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Erythromycin (333 mg, orally four times daily for 14 days)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo (orally four times daily for 14 days)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Erythromycin (333 mg)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Clindamycin (450 mg)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Compliance
Number of subjects: 126
Study: 7072831

Group type: EXPERIMENTAL
Intervention: Polycon contact lenses
Number of subjects: 8

Group type: COMPARATOR
Intervention: PMMA contact lenses
Number of subjects: 8
Study: 31350778

Group type: EXPERIMENTAL
Intervention: Nurse-coordinated integrated care model
Number of subjects: 392

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 392
Study: 28511243

Group type: EXPERIMENTAL
Intervention: Emotional arousal (measured via vocal fundamental frequency, f0) during social support interactions
Number of subjects: 44
Study: 25782136

Group type: EXPERIMENTAL
Intervention: Cognition mnemonic skill training (method of loci) for three 1-hour sessions
Number of subjects: 141

Group type: COMPARATOR
Intervention: No cognitive training (Control)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Cognition mnemonic skill training
Number of subjects: 141
Study: 24166407

Group type: EXPERIMENTAL
Intervention: Video gaming training with a platformer game for 2 months, at least 30 minutes per day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study: 21921817

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (CM) 20 g·d⁻¹ for 7 days
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (maltodextrin) 20 g·d⁻¹ for 7 days
Number of subjects: 22
Study: 19429735

Group type: EXPERIMENTAL
Intervention: Nurse-recorded NRS
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: Research-recorded NRS
Number of subjects: 528
Study: 17124389

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg/day for 3 months
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 83
Study: 15223991

Group type: EXPERIMENTAL
Intervention: MIDD1
Number of subjects: 77

Group type: COMPARATOR
Intervention: MIDD1/T1D
Number of subjects: 77

Group type: COMPARATOR
Intervention: MIDD2/T2D
Number of subjects: 77
Study: 12470528

Group type: EXPERIMENTAL
Intervention: Day 5 embryo transfer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Day 3 embryo transfer
Number of subjects: 0
Study: 9464734

Group type: EXPERIMENTAL
Intervention: 0.25 mg nitroglycerin
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 0.5 mg nitroglycerin
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 7637681

Group type: EXPERIMENTAL
Intervention: Natamycin (suspension, lozenges)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Nystatin (suspension)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Amphotericin B (suspension, lozenges)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Candida serology (indirect haemagglutination, indirect immunofluorescence and immunodiffusion precipitation)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Clinical picture, culture and serology
Number of subjects: 46
Study: 2236482

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural methods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 355881

Group type: COMPARATOR
Intervention: Therapies labeled as 'no different from control'
Number of subjects: 71

Group type: COMPARATOR
Intervention: Estimates of 90% confidence intervals for true improvement
Number of subjects: 71
Study: 31927774

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg and Tamsulosin 0.4 mg (DUT-TAM FDC)
Number of subjects: 489

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 489
Study: 30952918

Group type: EXPERIMENTAL
Intervention: Probiotic treatment for 12 weeks
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo treatment for 12 weeks
Number of subjects: 68
Study: 28180234

Group type: EXPERIMENTAL
Intervention: Tecarfarin (SAD)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Tecarfarin (MAD)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Tecarfarin (vs Warfarin)
Number of subjects: 137
Study: 26643000

Group type: EXPERIMENTAL
Intervention: Paclitaxel-Eluting Stent
Number of subjects: 279

Group type: COMPARATOR
Intervention: Conventional Stent
Number of subjects: 279
Study: 23770335

Group type: EXPERIMENTAL
Intervention: Cervarix(®) administered intradermally
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Gardasil(®) administered intradermally
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cervarix(®) administered intramuscularly
Number of subjects: 40

Group type: COMPARATOR
Intervention: Gardasil(®) administered intramuscularly
Number of subjects: 40
Study: 21527006

Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil
Number of subjects: 540

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study: 18812277

Group type: EXPERIMENTAL
Intervention: 6% HES (mW 130 kDa)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 6% HES (mW 200 kDa)
Number of subjects: 45

Group type: COMPARATOR
Intervention: 4% HA (MW 69 kDa)
Number of subjects: 45
Study: 16942451

Group type: EXPERIMENTAL
Intervention: Education by opinion leaders about whiplash guidelines
Number of subjects: 103

Group type: COMPARATOR
Intervention: Dissemination of guidelines mailed to physiotherapists
Number of subjects: 103
Study: 14563466

Group type: EXPERIMENTAL
Intervention: Mud pack treatment (30 mm thickness)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mud pack treatment (15 mm thickness)
Number of subjects: 20
Study: 10744097

Group type: EXPERIMENTAL
Intervention: 1 Hz transcranial magnetic stimulation of left temporoparietal cortex
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 12
Study: 8602588

Group type: EXPERIMENTAL
Intervention: Red wine
Number of subjects: 24

Group type: COMPARATOR
Intervention: White wine
Number of subjects: 24
Study: 1349493

Group type: EXPERIMENTAL
Intervention: Carteolol 10 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Carteolol 30 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Carteolol 60 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nadolol 40 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pindolol 30 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Carteolol
Number of subjects: 8
Study: 4078356

Group type: EXPERIMENTAL
Intervention: Clofazimine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Dapsone
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Dapsone with Clofazimine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Rifampicin alone (Control)
Number of subjects: 18
Study: 31805967

Group type: EXPERIMENTAL
Intervention: Corticosteroid therapy
Number of subjects: 336

Group type: COMPARATOR
Intervention: No corticosteroid therapy
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Cortisoltotal/CRP ratio > 3
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Cortisoltotal/CRP ratio < 3
Number of subjects: 336
Study: 30188739

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Waiting-List (WL)
Number of subjects: 39
Study: 26669629

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone
Number of subjects: 336

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 336
Study: 24776962

Group type: EXPERIMENTAL
Intervention: L‐T4 plus 100 μg/day of oral iodine
Number of subjects: 51

Group type: COMPARATOR
Intervention: L‐T4
Number of subjects: 51
Study: 22976782

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) plus 0.5% clarithromycin (CLM)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) plus placebo gel
Number of subjects: 63
Study: 19578138

Group type: EXPERIMENTAL
Intervention: Interactive CD with verbal feedback
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Interactive CD with additional practice with parents
Number of subjects: 96

Group type: COMPARATOR
Intervention: Interactive CD without verbal feedback
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Interactive CD
Number of subjects: 96
Study: 17335321

Group type: EXPERIMENTAL
Intervention: Melatonin (3‐12 mg/night; N = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (N = 20)
Number of subjects: 40
Study: 15461064

Group type: EXPERIMENTAL
Intervention: 40 microg Alprostadil (PGE1) in 250 ml 0.9% saline over 2 hours
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: 60 microg Alprostadil (PGE1) in 250 ml 0.9% saline over 2 hours
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo (250 ml 0.9% saline solution)
Number of subjects: 82
Study: 11559470

Group type: EXPERIMENTAL
Intervention: Molecular medicine interventions, specific details not provided.
Number of subjects: 0
Study: 9715151

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 38
Study: 8040490

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 107
Study: 2459635

Group type: EXPERIMENTAL
Intervention: ORG 10172 (low-molecular-weight heparinoid)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard heparin
Number of subjects: 14
Study: 29940904

Group type: EXPERIMENTAL
Intervention: TLC-PA-China (automated telephone counselor)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control (information pamphlet about benefits of physical activity)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: TLC-PA-China
Number of subjects: 210
Study: 28851798

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 25655533

Group type: EXPERIMENTAL
Intervention: Noninvasive positive pressure ventilation (NIPPV)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: NIPPV
Number of subjects: 86
Study: 24265181

Group type: EXPERIMENTAL
Intervention: Nebivolol (10 mg OD)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Lifestyle modification (5-10% weight loss via calorie restriction and physical activity)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Nebivolol plus lifestyle modification
Number of subjects: 45
Study: 21503128

Group type: EXPERIMENTAL
Intervention: Periodontal initial therapy (group I)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Professional mechanical tooth cleaning (PMTC) (group II)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Non-clinical therapy (control group)
Number of subjects: 66
Study: 17442688

Group type: EXPERIMENTAL
Intervention: Vildagliptin (10-400 mg)
Number of subjects: 16
Study: 15196286

Group type: EXPERIMENTAL
Intervention: Levocetirizine (5 mg/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Desloratadine (5 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 12220477

Group type: EXPERIMENTAL
Intervention: Oral provocation tests (OPT) for paracetamol hypersensitivity
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Skin eruptions
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Immediate reactions
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Atopy
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Aspirin/ibuprofen hypersensitivity
Number of subjects: 84
Study: 9635700

Group type: COMPARATOR
Intervention: Abdominal radiation therapy at 22.5 Gy in 22 fractions (low-dose arm)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Abdominal radiation therapy at 27.5 Gy in 27 fractions (high-dose arm)
Number of subjects: 125
Study: 7575042

Group type: EXPERIMENTAL
Intervention: Different associations and galenic forms of medicines (specific details not provided)
Number of subjects: 0
Study: 2521029

Group type: EXPERIMENTAL
Intervention: Desmopressin acetate (DDAVP), 0.3 microgram/kg, intravenously
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Desmopressin acetate (DDAVP)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Desmopressin acetate (DDAVP) and Placebo
Number of subjects: 20
Study: 788737

Group type: EXPERIMENTAL
Intervention: Flutiorex
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Norflutiorex
Number of subjects: 6

Group type: COMPARATOR
Intervention: Fenfluramine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 29672714

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg every 6 months for 3 years
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg every 6 months for 2/3 years
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg every 6 months for 5 years
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg every 6 months for 10 years
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study: 28893206

Group type: EXPERIMENTAL
Intervention: Blood flow restriction cycling group
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Traditional cycling group
Number of subjects: 75

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 75
Study: 26445392

Group type: EXPERIMENTAL
Intervention: Mini sling (Ophira)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Rectus fascia pubovaginal sling
Number of subjects: 100
Study: 22906795

Group type: EXPERIMENTAL
Intervention: Optoelectronic plethysmography (VC-Opto)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Spirometry (VC-Spiro)
Number of subjects: 20
Study: 21508007

Group type: EXPERIMENTAL
Intervention: Local activation times (LAT) during left atrial appendage (LAA) pacing at baseline
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Local activation times (LAT) during left atrial appendage (LAA) pacing at incomplete roof block
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Local activation times (LAT) during left atrial appendage (LAA) pacing at roof block
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Local activation times (LAT) during left atrial appendage (LAA) pacing at roof and mitral isthmus block
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: LAA to high posterior wall times >133 ms
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: High posterior wall to LAA times >125 ms
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Double potential >77 ms
Number of subjects: 45
Study: 18296926

Group type: EXPERIMENTAL
Intervention: Baseline IOP measurement
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Follow-up IOP measurement
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: IOP comparison by ethnicity
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: IOP comparison by gender
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Association between baseline IOP and myopic progression
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Association between IOP and axial length
Number of subjects: 104
Study: 16929992

Group type: EXPERIMENTAL
Intervention: 5 mL of 2% ropivacaine hydrochloride with epinephrine
Number of subjects: 20

Group type: COMPARATOR
Intervention: 5 mL of 0.9% saline with epinephrine (control)
Number of subjects: 20
Study: 15096969

Group type: EXPERIMENTAL
Intervention: DTPA (to estimate GFR)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: MAG3 (to produce images and curves)
Number of subjects: 92
Study: 11281468

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate 40 mg
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Misoprostol 400 microg
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Combination therapy (isosorbide mononitrate 40 mg and misoprostol 400 microg)
Number of subjects: 66
Study: 9850360

Group type: EXPERIMENTAL
Intervention: HFA-BDP 800 micrograms day-1
Number of subjects: 233

Group type: COMPARATOR
Intervention: CFC-BDP 1500 micrograms day-1
Number of subjects: 233
Study: 8008424

Group type: EXPERIMENTAL
Intervention: Tolperisone HCl, a centrally acting muscle relaxant
Number of subjects: 0
Study: 2520847

Group type: EXPERIMENTAL
Intervention: Misoprostol 50 mcg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misoprostol 100 mcg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misoprostol 200 mcg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misoprostol 400 mcg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misoprostol (all doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 0